EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Open Access · CC BY 4.0

Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib

Nico Gagelmann, Prithviraj Bose, Vikas Gupta, Donal P McLornan, Pankit Vachhani, Haifa-Kathrin Al-Ali, Haris Ali, Philipp Treskes, Sarah Buckley, Karisse Roman-Torres, Bart Scott

Clinical Lymphoma Myeloma and Leukemia · 2024

DOI: 10.1016/j.clml.2024.06.012 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024. Verfasst von Nico Gagelmann und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: n.gagelmann@uke.de. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Spleen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CTI Biopharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pacritinib is a JAK2/IRAK1/ACVR1 inhibitor that is approved in the United States for the treatment of patients with myelofibrosis who have a platelet count 10 g/dL), with no diminution in treatment effect in patients with severe thrombocytopenia or anemia. Among 159 patients evaluable for symptoms response, improvement in total symptom score (TTS) was similar across platelet subgroups. A ≥ 50% improvement of TSS occurred more frequently in patients with baseline hemoglobin 10 g/dL. Patients with baseline hemoglobin < 8 g/dL also experienced improved hemoglobin sustained over 24 weeks, whereas subgroups with less severe anemia had stable hemoglobin levels over time. Symptom improvement as assessed using the Patient Global Impression of Change instrument was generally consistent across platelet and hemoglobin subgroups. CONCLUSION: Pacritinib demonstrates consistent efficacy in patients with MF regardless of baseline platelet and hemoglobin counts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary MyelofibrosisSpleenHumansMaleFemaleMiddle AgedAgedProtein Kinase InhibitorsPyrimidinesTreatment OutcomeAged, 80 and overAdultBridged-Ring CompoundsPlatelet CountThrombocytopeniaCytopenia

Stichwörter der Autor:innen

AnemiaHemoglobinJAK2/IRAK1/ACVR1 inhibitor plateletThrombocytopenia

Substanzen

11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,1…Protein Kinase InhibitorsPyrimidinesBridged-Ring Compounds

Autor:innen und Institutionen

  • Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: n.gagelmann@uke.de.
  • Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK.
  • Department of Medicine, O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, AL.
  • Krukenberg Cancer Center, University Hospital Halle, Halle, Germany.

Förderung

  • CTI Biopharma

Zitieren

APA

Gagelmann, N., Bose, P., Gupta, V., McLornan, D. P., Vachhani, P., Al-Ali, H. K., Ali, H., Treskes, P., Buckley, S., Roman-Torres, K., & Scott, B. (2024). Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2024.06.012

Vancouver

Gagelmann N, Bose P, Gupta V, McLornan DP, Vachhani P, Al-Ali HK, et al. Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib. Clinical Lymphoma Myeloma and Leukemia. 2024. doi:10.1016/j.clml.2024.06.012

BibTeX
@article{Gagelmann2024,
  author = {Gagelmann, Nico and Bose, Prithviraj and Gupta, Vikas and McLornan, Donal P and Vachhani, Pankit and Al-Ali, Haifa-Kathrin and Ali, Haris and Treskes, Philipp and Buckley, Sarah and Roman-Torres, Karisse and Scott, Bart},
  title = {Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2024},
  doi = {10.1016/j.clml.2024.06.012}
}
Kostenlos starten →